Takeda Pharmaceutical Co Ltd 20-F for FY2024
Takeda Pharmaceutical Co Ltd (TAK)
20-F
2024-06-26
For: 2024-03-31
View Original
Added on
April 07, 2026
About this 20-F
Takeda Pharmaceutical Co Ltd filed this 20-F on June 26, 2024, covering the fiscal year ended March 31, 2024 (FY2024).
Headline figures
Fiscal year ended March 31, 2024, as reported in this filing, compared with the same period a year earlier where the filing states it.
- Revenue
- 4.26T JPY
- up 5.9% from 4.03T JPY a year earlier
- Net income
- 144.07B JPY
- down 54.6% from net income of 317.02B JPY a year earlier
- Diluted EPS
- 91.16 JPY
- down 54.9% from 201.94 JPY a year earlier